Summary

The North America market is expanding as a result of the rise in chronic disease prevalence, the rapid aging of the population, and technical improvements. Chronic diseases like diabetes, cancer, cardiovascular disease, and respiratory conditions are on the rise. In order to effectively treat and control these diseases, intravenous therapy is frequently needed. The demand for intravenous equipment, including catheters, infusion pumps, and administration sets, is driven by the rise in the prevalence of chronic diseases. Chronic diseases are more common as people age, and intravenous therapy is more necessary. Since intravenous equipment is essential for providing drugs, fluids, and nutrition to manage and treat various age-related disorders, the rising geriatric population is increasing demand for it. The market is growing significantly as a result of this demographic change. Intravenous treatment can be necessary to provide fluids and medications during surgical procedures. The need for intravenous equipment has increased in line with improvements in surgical methods and a rise in the number of operations performed. To support patient care during surgical procedures, operating rooms, ambulatory surgical facilities, and other surgical settings need a consistent supply of intravenous equipment. The market is expanding mainly due to the rising number of surgical procedures. IV therapy is widely used in North American hospitals, clinics, and emergency departments. It is estimated that over 3 million IV infusions are administered daily in the United States alone. This widespread utilization reflects the importance of IV therapy in treating a wide range of medical conditions, including dehydration, electrolyte imbalances, infections, and chronic diseases.

According to the research report "North America Intravenous (IV) Equipments Market Outlook, 2028," published by Bonafide Research, the Intravenous (IV) Equipments market was valued at more than USD 4 Billion in 2022. The aging population in North America is growing, leading to an increased demand for various healthcare services, including those involving IV therapy. Older individuals often require medical interventions that involve the use of IV equipment for medication administration and fluid management. Reimbursement policies and healthcare regulations play a crucial role in the adoption of medical technologies. North America, with its relatively favorable reimbursement policies, encourages healthcare providers to invest in advanced equipment, including IV devices. The use of IV equipment is subject to strict regulatory oversight in North America. The Food and Drug Administration (FDA) in the United States and Health Canada regulate the manufacturing, testing, and distribution of IV equipment, ensuring adherence to safety and performance standards. North America has a robust ecosystem for research and development in the medical field. The continuous investment in R&D activities by academic institutions, healthcare organizations, and private companies facilitates the innovation and development of new and advanced IV equipment. Patients in North America are generally well-informed about healthcare options and often actively participate in medical decisions. The awareness of the benefits of IV therapy in certain medical conditions and the demand for more convenient and effective treatment options can drive the adoption of IV equipment. North America has been at the forefront of integrating health information technologies into the healthcare system. Electronic health records (EHRs) and other health information systems can enhance the efficient use of IV equipment by providing accurate patient data, improving treatment outcomes, and reducing errors.

The United States, Canada, and Mexico make up the three countries that comprise the North American IV equipment market. During the forecast period, Mexico is anticipated to have the highest CAGR among them all. The United States, with its expansive and sophisticated healthcare infrastructure, has historically played a pivotal role in driving the growth of the regional IV equipment market. The country boasts advanced medical facilities, a robust network of healthcare professionals, and a high level of healthcare spending, contributing to the widespread adoption of IV equipment for various medical interventions. The continuous emphasis on research and development, coupled with a competitive landscape featuring key industry players, positions the United States as a hub for innovation in IV technologies. Mexico, with its expanding healthcare infrastructure and a growing focus on improving healthcare quality, has emerged as a key player in the North American IV equipment market. The country's efforts to enhance healthcare access and the increasing awareness of advanced medical treatments contribute to the adoption of IV equipment in various healthcare settings. Additionally, the presence of a diverse patient population with varying medical needs further fuels the demand for IV therapies.

Based on product market is bifurcated into IV catheters, infusion pumps, administration sets, securement devices, needless connectors, stopcocks and check valves, drip chambers and others. Among them majority of market is dominated IV catheters with significant market share. IV catheters are the most common invasive medical procedure in the United States. IV catheters are essential for delivering fluids, medications, and nutrition to patients. They are also used to draw blood for laboratory tests and to administer contrast dye for imaging studies. IV catheters can be used for short-term or long-term access. Short-term IV catheters are typically removed within 72 hours, while long-term IV catheters may be used for weeks or months. Continuous innovations in IV catheter technology, such as the development of safety features, reduced insertion trauma, and improved materials, make them increasingly popular among healthcare providers. Advanced catheter designs aim to enhance patient comfort, reduce the risk of complications, and improve overall efficiency in intravenous therapy. In addition to the cost of the catheter itself, there are also other costs associated with IV catheter use, such as the cost of insertion is more than $25. Furthermore, North America faces a significant burden of respiratory diseases, including chronic obstructive pulmonary disease (COPD), asthma, and respiratory infections. The high prevalence of these conditions necessitates frequent medical interventions, including intravenous therapies, to manage symptoms and provide relief.

In terms of end user segment market is bifurcated into hospitals, clinics, home care settings and others. The rise of outpatient care and ambulatory services has led to an increased number of clinics across North America. Outpatient clinics often handle a wide range of medical treatments and procedures, including intravenous therapies. As clinics become more prevalent, the demand for IV equipment within these settings grows. Clinics are often more accessible and convenient for patients, particularly for routine or minor medical procedures. The ease of access to clinics for intravenous therapies, vaccinations, and other treatments contributes to the growing demand for IV equipment in these settings. There is a growing emphasis on preventive care, and clinics play a crucial role in providing preventive services. Intravenous therapies, such as vaccinations and nutritional support, are essential components of preventive care, contributing to the increased adoption of IV equipment in clinics. Clinics offering infusion therapy services, which involve the administration of medications through intravenous routes, are on the rise. Conditions such as autoimmune diseases, infections, and certain chronic illnesses require infusion therapy, boosting the demand for IV equipment in clinics. Clinics often provide cost-effective healthcare solutions compared to hospitals. The affordability and efficiency of clinics make them attractive settings for various medical treatments, including those involving intravenous therapies. The cost-effectiveness of clinics contributes to the growing market for IV equipment in this segment.

Recent Developments:

• In October 2022, Baxter announced the launch of its new Spectrum IQ Infusion Pump, which is designed to improve patient safety and medication administration accuracy. The pump features a number of new safety features, including a bar-coded medication administration system and a software-based lockout mechanism.

• In August 2022, Baxter announced that it had received FDA clearance for its new Novum IQ Syringe Infusion Pump. The Novum IQ is a smaller, lighter, and more portable infusion pump that is designed for use in home and ambulatory settings.

• In July 2022, B. Braun launched its new Introcan Safety 2 IV Catheter with one-time blood control. The device is designed to reduce the risk of blood backflow and needle-stick injuries.

• In April 2022, ICU Medical announced that it had received FDA clearance for its new Sharpsmart Needleless Access Device. The Sharpsmart is a needleless access device that is designed to reduce the risk of needlestick injuries.

Companies Covered in this report:

Becton, Dickinson and Company, B. Braun Melsungen AG, Baxter International Inc., ICU Medical, Inc., Medtronic PLC, Moog Inc., Terumo Corporation, Teleflex Incorporated, IRadimed Corporation, Amsino International, Inc. , Cardinal Health, Inc.

Considered in this report

• Geography: North America
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report

• North America IV Equipments market Outlook with its value and forecast along with its segments
• Country-wise IV Equipments market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• United States
• Canada
• Mexico

By Product:

• IV Catheters
• Infusion Pumps
• Administration Sets
• Securement Devices
• Needless Connectors
• Stopcocks and Check Valves
• Drip Chambers
• Others

By End User:

• Hospital
• Clinics
• Home Care Settings
• Others

By Indication:

• Cardiovascular Disorders & Hypertension
• Pregnancy
• Diabetes
• Respiratory Diseases
• Cancer
• Movement Disorders
• Hearing Disorders
• Wound Care
• Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the IV Equipments industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.








***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents